110 related articles for article (PubMed ID: 23789610)
21. [Interferon-alpha and PUVA therapy for mycosis fungoides].
Marschalkó M; Kovács J; Somlai B; Berecz M; Hídvégi B; Hársing J; Désaknai M; Horváth A
Orv Hetil; 2001 Sep; 142(37):2021-3. PubMed ID: 11582733
[TBL] [Abstract][Full Text] [Related]
22. The treatment of mycosis fungoides.
Mestel DS; Beyer M; Steinhoff M; Sterry W; Assaf C
G Ital Dermatol Venereol; 2008 Dec; 143(6):395-408. PubMed ID: 19169212
[TBL] [Abstract][Full Text] [Related]
23. Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides.
Coors E
Dermatol Clin; 2008 Jan; 26 Suppl 1():33-5. PubMed ID: 18405185
[No Abstract] [Full Text] [Related]
24. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
Weber F; Schmuth M; Sepp N; Fritsch P
Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
[TBL] [Abstract][Full Text] [Related]
25. Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):47-51. PubMed ID: 6164214
[TBL] [Abstract][Full Text] [Related]
26. Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience.
Zachariae H; Thestrup-Pedersen K
Acta Derm Venereol; 1987; 67(5):433-7. PubMed ID: 2448996
[TBL] [Abstract][Full Text] [Related]
27. Erythema gyratum repens-like eruptions with large cell transformation in a patient with mycosis fungoides.
Holcomb M; Duvic M; Cutlan J
Int J Dermatol; 2012 Oct; 51(10):1231-3. PubMed ID: 21726213
[No Abstract] [Full Text] [Related]
28. [Annular erythema in a 78-year old woman].
Booken N; Utikal J; Hildenbrand R; Goerdt S; Klemke CD
J Dtsch Dermatol Ges; 2008 Apr; 6(4):321-3. PubMed ID: 18377564
[No Abstract] [Full Text] [Related]
29. Treatment of mycosis fungoides with recombinant interferon-alpha 2a2 alone and in combination with etretinate.
Thestrup-Pedersen K; Hammer R; Kaltoft K; Søgaard H; Zachariae H
Br J Dermatol; 1988 Jun; 118(6):811-8. PubMed ID: 3042011
[TBL] [Abstract][Full Text] [Related]
30. Granulomatous mycosis fungoides responsive to acitretin and UVA1 treatment.
Shao EX; Mortimore R; Sander C; Wheller L
Australas J Dermatol; 2019 Aug; 60(3):e239-e240. PubMed ID: 30656670
[No Abstract] [Full Text] [Related]
31. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
Huang J; Cowper S; Moss J; Girardi M
J Drugs Dermatol; 2013 Apr; 12(4):487-9. PubMed ID: 23652902
[TBL] [Abstract][Full Text] [Related]
32. [Retinoid oral photochemotherapy (RePUVA) as a combination treatment of mycosis fungoides].
Hunziker T; Zala L; Krebs A
Dermatologica; 1983; 166(3):165-8. PubMed ID: 6852330
[No Abstract] [Full Text] [Related]
33. Longterm remission of tumor-stage mycosis fungoides following total-skin electron-beam radiotherapy.
Stallmeister T; Dieckmann K; Rehberger A; Jurecka W
Eur J Dermatol; 1998 Jun; 8(4):240-2. PubMed ID: 9649676
[TBL] [Abstract][Full Text] [Related]
34. Denileukin diftitox plus total skin electron beam radiation in patients with treatment-refractory cutaneous T-cell Lymphoma (mycosis fungoides): report of four cases.
Buder K; Müller PA; Beckmann G; Ugurel S; Bröcker EB; Becker JC
Acta Derm Venereol; 2014 Jan; 94(1):94-6. PubMed ID: 23756575
[No Abstract] [Full Text] [Related]
35. A patient with plaque-stage mycosis fungoides has successfully been treated with long-term administration of IFN-gamma and has been in complete remission for more than 6 years.
Horikoshi T; Onodera H; Eguchi H; Hanada N; Fukuzawa K; Takahashi M; Ishihara K; Ikeda S
Br J Dermatol; 1996 Jan; 134(1):130-3. PubMed ID: 8745899
[TBL] [Abstract][Full Text] [Related]
36. [Mycosis fungoides].
Sasaki M; Oshimi K
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):272-5. PubMed ID: 9851137
[No Abstract] [Full Text] [Related]
37. Total skin electron beam radiotherapy for patients who have mycosis fungoides.
Jones G; Wilson LD; Fox-Goguen L
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1421-34. PubMed ID: 14710893
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
39. Aspects of the treatment of mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O; Fischer T; Nordentoft A; Zachariae H
Cutis; 1980 Feb; 25(2):155-7, 160-1. PubMed ID: 6153595
[TBL] [Abstract][Full Text] [Related]
40. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
D'Acunto C; Gurioli C; Neri I
J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
